Peter Anastasiou

Peter Anastasiou serves as Capsida’s Chief Executive Officer and member of the board of directors. He has 30 years of experience managing multifunctional and diverse organizations, leading them to achieve common goals.

Before Capsida, Mr. Anastasiou served as an Executive Vice President, member of the executive committee, and President of North America at Lundbeck. As President of Lundbeck’s North American business operations, Mr. Anastasiou led as many as 1,200 employees and achieved annual net revenues of $1.5 billion, playing a pivotal role in developing and launching multiple products and building the company’s cross-functional capabilities. Prior to Lundbeck, he held management roles at Neuronetics, Inc., Bristol-Myers Squibb Company, and Eli Lilly and Company. Mr. Anastasiou served on the Board of PhRMA for more than four years. He currently serves on the board of Harmony Biosciences (NASDAQ: HRMY) and the global advisory board for the Healthcare Businesswomen’s Association and was named the 2019 HBA Honorable Mentor and one of the 2020 PharmaVOICE 100.

He holds an M.B.A. from the Kelley School of Business at Indiana University and a B.A. in economics and management from Albion College.